Skip to content

Hypocaloric Enteral Nutrition in the Critically Ill Patient

Randomized Controlled Trial of Hypocaloric Hyperproteic Enteral Nutrition in the Critically Ill Patient

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02577211
Acronym
hipoentnut
Enrollment
120
Registered
2015-10-16
Start date
2013-12-31
Completion date
2015-07-31
Last updated
2015-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill

Keywords

Critically ill, Enteral nutrition

Brief summary

The aim of this study is to compare two nutritional regimes in critically ill patients. Patients will be randomized to standard care (25 kcal per kg) or to hypocaloric nutrition (15 kcal per kg). Both regimes will recive 1,7 g/Kg/dia The main outcome will be the SOFA (sequential organ failure assessment) score. The hypothesis is that hypocaloric hyperproteic diet decreases the incidence of organic failure in these patients.

Detailed description

The research site will be the intensive care unit (ICU) of Hospital Universitario San Ignacio; eligible patients will \>18 years of age with a presumed fasting period of at least 96 hours, with no contraindications for enteral nutrition. Patients with parenteral nutrition, pregnancy, diabetes, liver failure, renal failure, transplant protocol, or admitted from another hospital will be excluded. In all patients, the following information will be collected daily: enteral formula in ml, carbohydrate intake, insulin required (in IU), presence of hyper or hypoglicemia, presence of infections, among others. The SOFA score will be assessed every two days until discharge from ICU.

Interventions

DIETARY_SUPPLEMENTHipocaloric enteral nutrition

15 kcal/Kg of body weight

DIETARY_SUPPLEMENTNormocaloric enteral nutrition

25 kcal/kg of body weight

Sponsors

Hospital Universitario San Ignacio
CollaboratorOTHER
Pontificia Universidad Javeriana
CollaboratorOTHER
Lafrancol S.A.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* \>18 years * Estimated fasting period of at least 96 hours * ICU patients

Exclusion criteria

* Parenteral nutrition * Pregnancy * Diabetes * Liver failure * Transplantation or in transplant protocol * Previous nutrition support * Chronic Renal failure

Design outcomes

Primary

MeasureTime frameDescription
Change in the intial SOFA (Sequential Organ Failure Assessment) score at 48 hours.48 hours after the onset of nutritionSOFA score evaluates six systems: respiratory, cardiovascular, coagulation, Central Nervous System, liver and renal. Each system gets a score from 0 (normal) to 4 (abnormal) and the sum of each score defines the final SOFA score, which 24 is the maximum score (high risk of morality) and 0 is the minimum score (low risk of mortality).

Secondary

MeasureTime frameDescription
Units of insulin require in a dayWithin the first 4 days after the onset of nutritionThis is an indirect measure of glycemic control, and is reported as a daily average of the units of insuline require in the first 4 days since nutritional regimen starts.
Number of days the patient requires mechanical ventilation.Within the first 28 days after the onset of nutritionMeasure daily
Number of days in the intensive care unitWithin the first 28 days after the onset of nutritionMeasure daily
Mortality to 28 days28 days after the onset of nutritionWe will interview each patient 28 days after the start of the study to assess the global mortality

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026